Multifo cal angiosarcoma ofthe scalp is uncommon . Its riskfactors include a history ofradiotherapy and possibly Sllll exposure. Angiosarcoma is an aggressiv e tumor with a high propensity for both local recurr ence and distant metastasis. Overall, the prognosis is poor. The size ofthe lesion is an important prognostic fa ctor. Treatment modalities include surgery with wide margins (with or without adjuvant therapy) and multidru g chemotherapy, followed by radiotherapy. The local failure rate is high.
liferation, consistent with a diagnosis of a high-grade angiosarcoma of the scalp . Microscopically, the tumor showed a diffuse infiltrative pattern of growth within the dermis and subcutaneous tissue, with alternating solid areas and well-formed vascular channels (figure 2).Marked nuclear pleomorphism and high mitotic activity were present in the lining endothelial cells (figure 3). A brisk inflammatory infiltrate was intimately associated with the tumor. The patient underwent chemotherapy and radical radiotherapy, and had a satisfactory respon se.
Discussion
Cutaneous angiosarcoma is an aggre ssive, malignant vascular tumor that, in the absence of radiation or lymphedema, has a great predilection for the skin of the face and scalp . Usually it occurs during the sixth and seve nth decades of life, and it is more commo n in men. These tumors accou nt for less than I% of all sarcomas and all head and neck tumors; 50% of all angiosarcomas occur in the head and neck area.' The most com mon sites in this area include the scalp, temple, and cheek; the lips, nose, and ears may also be affected. Most patients with head and neck angio sarcoma present clinically with multiple foci of disease that have a marked tendency for local spread in surface and depth.' Accordingly, three clinical pattern s have been described: superficial spreading, nodular, and ulcerating. '
There is no clear-cut , demon strated etiologic agent, although previous radiation, thorium dio xide contrast, chronic lymphedema, and sun exposure have been implicated.' Mutations ofthe p53 gene have been implicated as the major pathwa y in the development of angiosarcoma. In a study by Naka et aI, 7 of 13 patients (53.8%) with angio sarcoma of the head and neck region had mutations in the p53 gene.'
Histologica lly, angiosarcoma is characterized by freely anastomosing channels lined with atypical endothelial the # 1 Best Seller-an OTO-MED original
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fax 520-453-3809 cells. The histopathologic grade is based on the degree of differentiation of the vascular space s and of cytologic atypia in the lining endotheli al cells. Patients with angiosarcoma of the head and neck are usually of high histologic grade.' The differential diagnosis includes reactive or neopla stic vascul ar proliferations, such as pyogenic granuloma , Kaposi' s sarcoma, hemangiop ericytom a, and epithelioid hemangi oendothelioma." Also included in the differential diagnosi s are two primary cutaneous neoplasms: adnexal scalp tumors and malignant melanom a.
Because of its tendency toward diffuse, clinically undetectable local spre ad, cutaneous angiosarcoma is difficult to treat with surger y alone, althou gh a con sensus for treatment has not been reached. Some autho rs advocate radical excision with region al lymph node clearance , with or without adjuvant radiotherapy?" Others recommend prim ary radiation therapy , with surgery held in reserve. Multidrug systemic or intra-arterial chemotherapy (adriamycin, paclitaxel, or vincristine) followed by radiother apy is reserved for unrese ctable lesions . Patients who undergo both radical surgery and adjuv ant radiothe rapy have a better prognosis (5-year surviv al: 67 %) than those who undergo either chemotherapy plus radioth erapy or surgery alone.' Thi s emphasizes the importance of early diagnosi s and treatment."
A study by Willers et al concluded that patients with angios arcoma have a considerably worse prognosis than those who have other soft tissue sarcom as.to They found that the rates of actuarial 5-year survival, locoregional control, and freedom from distant metastasis were 31%, 24%, and 42%, respe ctively. They also suggested that tumor grade, tumor size, and direct tumor extension affects outcomes. In another report, Morri son et al suggested that radiation is an effecti ve modality for treating local disease, especi ally when it is admini stered after surg ical resection ofa mac roscopic tumor."The y reported that 5-year actuari al survival rates for irradiated patients with and without clinic al disease were 24% and 50%, respecti vely.
The results at our institution publi shed in 1994 suggest a 33 % survival, with only 20% of patient s disease-free at 5 years." In our experience, the size of the tumor was the most important predictor of mortality; mortality was 100% in patien ts whose tumor s were larger than 10 ern, compared with 67% amon g patients whose tumors were smaller than 10cm . Other prognostic factor s mentioned in literature include DNA ploidy, the mode of treatment, and mitoti c counts . A high level of diploid DNA , comb ination surgery and radiotherapy , tumor size, and low mitotic counts were independent progno stic factor s.JLIZ In contrast, a study by Karpeh The treatment of regional nodal basins is controversial. Most authors do not advocate elective treatment of the neck . The incidence of regional metastasis has been reported to be 10 to 15%.8Lymph node clearance has been recommended for lateralized lesions, but not for midline lesion s."A study by Fong et aI, who reviewed lymph node metastasis from soft tissue sarcoma in adults, revealed that of all soft tissue sarcomas, angiosarcoma had the highe st incidence oflymph node metastasis (13 .5%).14In a study by Aust et aI, most patients who experienced regional recurrence had tumors larger than 7 ern." They recommend regional neck node dissection or elective neck irradiation for patients whose tumors are larger than 7 em .
Lydi att et al reported that 78 % of patients experienced local recurrence, and death was due to uncontrolled local disease in combination with dist ant metastases." Common sites of distant metastasis include the lung, liver, and bone. Patients whose lesion s are unresectable have a dismal pro gnosis; median survival is less than 18 month s with chemotherapy, with or without radiation. The chemotherapeutic drugs of choice are adriamycin and paclit axel.
Conclusion
Patients with cutaneous angios arcom a of the head and neck usually have high-grade histology and multifocal disease. The overall progno sis is very poor; 5-ye ar survival with combined-modality therapy is onl y 5 to 30%. Locoregional recurrence occurs within the first 2 years; the lungs are the most common site for distant metastasis.
